Chinese PLA General Hospital
Beijing, Beijing Municipality, 100853, China
NCT Number: NCT05456230
This research project is an observational cohort study by prospective chart review of patients that underwent surgery in multi-centers, China, in the years 2020-2022. The purpose of this study is to compare the occurrence of postoperative delirium With Midazolam and Without Midazolam During Non-cardiac Surgery in Elders.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Beijing, Beijing Municipality, 100853, China
Post operative delirium will be diagnosed using the 3D- CAM(Confusion Assessment Method) which tests for four features with a series of questions. The features include 1) acute onset and fluctuating course,2) inattention,3) disorganized thinking and 4) altered level of consciousness. Diagnosis of delirium is made if features 1 and 2 and either 3 or 4 are present.
The demographic data of the patients,type and site of surgery will be noted. Preoperative hemoglobin, serum electrolytes and blood urea will be recorded. The intraoperative factors like duration of surgery and anaesthesia,use of intravenous fluids ,blood loss, number blood units transfused and opioid use will be studied at the time of surgery. The time to emergence and extubation following the completion of surgery will be noted.
The postoperative factors like postoperative pain, nausea and vomiting, fever,hemoglobin,serum electrolytes and blood urea will be noted.
Preoperative and postoperative pain will be assessed using the numerical rating score on a scale of one to ten.
The association of various preoperative,intraoperative and postoperative factors with POD will be determined.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Geriatric surgical patients ≥65 years old Underwent elective non-cardiac surgery
Exclusion criteria
History of neuropsychiatric diseases including delirium, mental disorders, Parkinson, dementia, etc.; The operation was cancelled due to various reasons after the patient was enrolled; severe liver disease; severe renal dysfunction defined as either having creatinine clearance < 30 ml/min or being dialysis-dependent; Patients who undergo second operation in a short period; Refused to participate in the study.
Midazolam as a premedication was given as the patient is taken to the operating room and typically within 15 minutes of anesthetic induction.
Other names: benzodiazepines
Time frame: Day 1 postoperatively
Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily
Time frame: Day 2 postoperatively
Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily
Time frame: Day 3 postoperatively
Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily
Time frame: Day 4 postoperatively
Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily
Time frame: Day 5 postoperatively
Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily
Time frame: Day 7 postoperatively
Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily
Time frame: 1 year
collection of clinical data in the medical record and follow-up update
Chinese PLA General Hospital
Other
Comparison of Postoperative Delirium in Elders Anaesthetised With Midazolam and Without Midazolam During Non-cardiac Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05823844
Confusion, Delirium
New York, United States
View Trial DetailsNCT07714928
Cognition Disorders, Cognitive Dysfunction
Örebro, Sweden
View Trial DetailsNCT05574400
Alzheimer Disease, Brain Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT06115031
Confusion, Delirium
Seoul, South Korea
View Trial Details